Your browser doesn't support javascript.
loading
Infection of human lymphomononuclear cells by SARS-CoV-2
Marjorie C Pontelli; Italo A Castro; Ronaldo B Martins; Flavio P Veras; Leonardo La Serra; Daniele C Nascimento; Ricardo S Cardoso; Roberta Rosales; Thais M Lima; Juliano P Souza; Diego B Caetite; Mikhael HF Lima; Juliana T Kawahisa; Marcela C Giannini; Leticia P Bonjorno; Maria IF Lopes; Sabrina S Batah; Li Siyuan; Rodrigo L Assad; Sergio CL Almeida; Fabiola R Oliveira; Maira N Benatti; Lorena LF Pontes; Rodrigo C Santana; Fernando C Villar; Maria A Martins; Thiago M Cunha; Rodrigo T Calado; Jose C Alves-Filho; Dario S Zamboni; Alexandre Fabro; Paulo Louzada-Junior; Paulo Louzada-Junior; Rene DR Oliveira; Fernando Q Cunha; Eurico Arruda.
Affiliation
  • Marjorie C Pontelli; Virology Research Center, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Italo A Castro; Virology Research Center, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Ronaldo B Martins; Virology Research Center, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Flavio P Veras; Center of Research in Inflammatory Diseases (CRID), University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Leonardo La Serra; Virology Research Center, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Daniele C Nascimento; Center of Research in Inflammatory Diseases (CRID), University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Ricardo S Cardoso; Virology Research Center, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Roberta Rosales; Department of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Thais M Lima; Virology Research Center, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Juliano P Souza; Virology Research Center, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Diego B Caetite; Center of Research in Inflammatory Diseases (CRID), University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Mikhael HF Lima; Center of Research in Inflammatory Diseases (CRID), University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Juliana T Kawahisa; Center of Research in Inflammatory Diseases (CRID), University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Marcela C Giannini; Center of Research in Inflammatory Diseases (CRID), University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Leticia P Bonjorno; Center of Research in Inflammatory Diseases (CRID), University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Maria IF Lopes; Center of Research in Inflammatory Diseases (CRID), Divisions of Clinical Immunology; University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Sabrina S Batah; Department of Pathology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Li Siyuan; Department of Pathology, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Rodrigo L Assad; Center of Research in Inflammatory Diseases (CRID), Divisions of Clinical Immunology, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Sergio CL Almeida; Center of Research in Inflammatory Diseases (CRID), Divisions of Clinical Immunology, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Fabiola R Oliveira; Center of Research in Inflammatory Diseases (CRID), Divisions of Clinical Immunology, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Maira N Benatti; Center of Research in Inflammatory Diseases (CRID), Divisions of Clinical Immunology, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Lorena LF Pontes; Blood Center of Ribeirao Preto, Ribeirao Preto, Brazil
  • Rodrigo C Santana; Center of Research in Inflammatory Diseases (CRID), Infectious Diseases, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Fernando C Villar; Center of Research in Inflammatory Diseases (CRID), Infectious Diseases, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Maria A Martins; Center of Research in Inflammatory Diseases (CRID), Intensive Care Unit, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Thiago M Cunha; Center of Research in Inflammatory Diseases (CRID), University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Rodrigo T Calado; Blood Center of Ribeirao Preto, Ribeirao Preto, Brazil
  • Jose C Alves-Filho; Center of Research in Inflammatory Diseases (CRID), University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Dario S Zamboni; Center of Research in Inflammatory Diseases (CRID), Department of Cell and Molecular Biology and Pathogenic Bioagents, Ribeirao Preto Medical School
  • Alexandre Fabro; Department of Pathology, Ribeirao Preto Medical School University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Paulo Louzada-Junior; Center of Research in Inflammatory Diseases (CRID), Divisions of Clinical Immunology, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Paulo Louzada-Junior; Center of Research in Inflammatory Diseases (CRID), Divisions of Clinical Immunology, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Rene DR Oliveira; Center of Research in Inflammatory Diseases (CRID), Divisions of Clinical Immunology, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Fernando Q Cunha; Center of Research in Inflammatory Diseases (CRID), University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
  • Eurico Arruda; Virology Research Center, Ribeirao Preto Medical School, University of Sao Paulo, Ribeirao Preto, Sao Paulo, Brazil
Preprint in English | bioRxiv | ID: ppbiorxiv-225912
ABSTRACT
Although SARS-CoV-2 severe infection is associated with a hyperinflammatory state, lymphopenia is an immunological hallmark, and correlates with poor prognosis in COVID-19. However, it remains unknown if circulating human lymphocytes and monocytes are susceptible to SARS-CoV-2 infection. In this study, SARS-CoV-2 infection of human peripheral blood mononuclear cells (PBMCs) was investigated both in vitro and in vivo. We found that in vitro infection of whole PBMCs from healthy donors was productive of virus progeny. Results revealed that monocytes, as well as B and T lymphocytes, are susceptible to SARS-CoV-2 active infection and viral replication was indicated by detection of double-stranded RNA. Moreover, flow cytometry and immunofluorescence analysis revealed that SARS-CoV-2 was frequently detected in monocytes and B lymphocytes from COVID-19 patients, and less frequently in CD4+T lymphocytes. The rates of SARS-CoV-2-infected monocytes in PBMCs from COVID-19 patients increased over time from symptom onset. Additionally, SARS-CoV-2-positive monocytes and B and CD4+T lymphocytes were detected by immunohistochemistry in post mortem lung tissue. SARS-CoV-2 infection of blood circulating leukocytes in COVID-19 patients may have important implications for disease pathogenesis, immune dysfunction, and virus spread within the host.
License
cc_by_nc_nd
Full text: Available Collection: Preprints Database: bioRxiv Type of study: Prognostic study Language: English Year: 2020 Document type: Preprint
Full text: Available Collection: Preprints Database: bioRxiv Type of study: Prognostic study Language: English Year: 2020 Document type: Preprint
...